Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of FBXO32 mRNA | increases expression | 19933214
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of FBXO32 mRNA | decreases expression | 18648102
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 18346979
|
D000638 |
Amiodarone |
Amiodarone results in increased expression of FBXO32 mRNA | increases expression | 19774075
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FBXO32 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic affects the expression of FBXO32 mRNA | affects expression | 18414638
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of FBXO32 mRNA | decreases expression | 20106945
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of FBXO32 mRNA | increases expression | 16474171
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of FBXO32 mRNA | decreases expression | 18042831
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of FBXO32 mRNA | decreases expression | 16002434
|
D004317 |
Doxorubicin |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 18346979
|
D004317 |
Doxorubicin |
AKT1 protein inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 18346979
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of FBXO32 mRNA | increases expression | 18346979
|
D004958 |
Estradiol |
Estradiol results in increased expression of FBXO32 mRNA | increases expression | 16474171
|
D019833 |
Genistein |
Genistein results in increased expression of FBXO32 mRNA | increases expression | 16474171
|
C002963 |
geranylgeranyl pyrophosphate |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 19406843
|
C002963 |
geranylgeranyl pyrophosphate |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] | decreases reaction|increases expression | 19406843
|
C002963 |
geranylgeranyl pyrophosphate |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 19406843
|
C002963 |
geranylgeranyl pyrophosphate |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] | decreases reaction|increases expression | 19406843
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of FBXO32 mRNA | increases expression | 17131360
|
D008148 |
Lovastatin |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 19406843
|
D008148 |
Lovastatin |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] | decreases reaction|increases expression | 19406843
|
D008148 |
Lovastatin |
Lovastatin results in increased expression of FBXO32 mRNA | increases expression | 19406843
|
D008148 |
Lovastatin |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 19406843
|
D008148 |
Lovastatin |
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] | decreases reaction|increases expression | 19406843
|
D008148 |
Lovastatin |
Lovastatin results in increased expression of FBXO32 mRNA | increases expression | 19406843
|
D008148 |
Lovastatin |
Lovastatin results in increased expression of FBXO32 protein | increases expression | 19406843
|
D008148 |
Lovastatin |
Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 19406843
|
D008148 |
Lovastatin |
Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] | decreases reaction|increases expression | 19406843
|
D008798 |
Mevalonic Acid |
Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 19406843
|
D008798 |
Mevalonic Acid |
Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein] | decreases reaction|increases expression | 19406843
|
C095716 |
N-acetyl-S-geranylgeranyl-cysteine |
N-acetyl-S-geranylgeranyl-cysteine results in increased expression of FBXO32 mRNA | increases expression | 19406843
|
C095716 |
N-acetyl-S-geranylgeranyl-cysteine |
N-acetyl-S-geranylgeranyl-cysteine results in increased expression of FBXO32 protein | increases expression | 19406843
|
C041786 |
palm oil |
palm oil results in decreased expression of FBXO32 mRNA | decreases expression | 18042831
|
C032208 |
perilla alcohol |
perilla alcohol results in increased expression of FBXO32 mRNA | increases expression | 19406843
|
C032208 |
perilla alcohol |
perilla alcohol results in increased expression of FBXO32 protein | increases expression | 19406843
|
C032208 |
perilla alcohol |
perilla alcohol results in increased expression of FBXO32 mRNA | increases expression | 19406843
|
C032208 |
perilla alcohol |
perilla alcohol results in increased expression of FBXO32 protein | increases expression | 19406843
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of FBXO32 mRNA | increases expression | 16474171
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of FBXO32 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA | increases expression | 18495758
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of FBXO32 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA | increases expression | 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.70 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.41 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.89 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.88 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.88 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.88 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.88 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.31 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.31 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.06 | 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.40 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.81 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.92 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.67 | 20041841 18218290 18057881 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.83 | 16835338 12569548 18414634 16251483 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.74 | 15238619 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.16 | 12928151 19371607 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.79 | 19698954 18651412 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.87 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
8.58 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.58 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.67 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.55 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.72 | 11985600 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.68 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.62 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.62 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
4.62 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
4.62 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.62 | 17369602 19526202 11325840 15939500 16935488 16264153 15668708 16096432 16595493 18628466 15994142 18695136 17426702 16826403 16322301 15993339 17983394 15136595 18382427 15692762 16115903 18234424 15567936 15634643 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.62 | 16675129 17018787 12948864 14630087 17289903 18497071 17261762 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
4.62 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.62 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.31 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.66 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.68 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.51 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.62 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
8.62 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.62 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.62 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
8.62 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.84 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.31 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.31 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
10.47 | 15504454 18922899 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.47 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
10.47 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.47 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.94 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.28 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.43 | 16952015 15476868 16278810 16269455 17928571 17382496 17007740 18627295 17924179 15505089 16455267 16731534 15792986 16651473 15811867 16364871 16612575 17519947 17329180 17308081 17131338 16109756 16242529 17974986 17351982 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.80 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.80 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
7.16 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.16 | 16332659 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.18 | 18022660 16973168 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.93 | 18974383 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.31 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.31 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.03 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.04 | 9022650 19486331 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.60 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 12621046 16354765 15668235 15340226 8697196 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.26 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.88 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
2.88 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.56 | 16140633 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.66 | 11906362 2524372 14531868 18759878 8970840 8156756 11298694 12868966 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.35 | 2952479 3621924 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.65 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.20 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.20 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.28 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.54 | 18289764 9653073 18692083 1440618 8291058 7440962 9022650 6482804 16192314 6679447 11289319 9328219 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
11.54 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.54 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
11.54 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.54 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.74 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.74 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.34 | 18367378 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.24 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
3.79 | 15138306 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.44 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
11.95 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.95 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
11.95 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.89 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.01 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.24 | 17637181 15821434 15328337 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.23 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.23 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
7.52 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
7.52 | 17967931 18296743 19004024 19551842 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.88 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.87 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.44 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.12 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.12 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.41 | 6392382 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.01 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.01 | 16598420 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.89 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.43 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.18 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.18 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.38 | 16879835 17875725 14766674 16495754 16144979 16244372 18674790 18006777 17888722 16244371 12587719 16707910 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.25 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.76 | 15692506 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.25 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.37 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
8.04 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.04 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.88 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.28 | 17606976 15147373 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.60 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
8.70 | 9751232 8137927 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
8.70 | 21332399 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.32 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.47 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.79 | 15034207 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.04 | 9931084 11953799 16076760 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18670907 18850075 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.41 | 16093927 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.36 | 17991464 18020914 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.89 | 20412841 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
7.89 | 17237260 17963957 12878042 17255318 9205823 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.89 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
16.86 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
16.86 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
16.86 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
16.86 | 14714311 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.49 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.87 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.84 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.91 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.91 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.01 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.95 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.95 | 15610895 |
MESH:D007938 |
Leukemia |
|
Genistein |
2.95 | 18980019 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.01 | 16085563 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.45 | 17339181 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.55 | 15821434 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.40 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.80 | 18296743 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.10 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.55 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.55 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.55 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
6.55 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.55 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.51 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
7.09 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.09 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.09 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
13.39 | 598648 6587162 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
13.39 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
13.39 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.39 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.46 | 17391786 11989578 15350150 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.27 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.33 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.86 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
4.71 | 17976673 17306315 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.71 | 18816296 20064080 18569708 18520028 20464547 6695378 20869020 20135361 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.71 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.71 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.35 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.92 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.67 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.42 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.47 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.47 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
9.47 | 14578162 12929590 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.33 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.27 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.00 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.36 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.07 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.64 | 17415656 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.75 | 17974566 12754197 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.77 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.77 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
8.60 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.60 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.13 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.13 | 17141266 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.64 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.64 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.10 | 11141357 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.58 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.62 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.87 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
22.23 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
22.23 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
22.23 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
22.23 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.05 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.05 | 16620997 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.19 | 15555623 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.23 | 17056641 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.25 | 19632207 21332399 20518802 18674790 18457598 17217161 16723640 20132043 11836018 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.29 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.87 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.16 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.94 | 16169203 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.99 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.84 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.67 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.67 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.67 | 19005980 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.33 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.34 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.03 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.84 | 15371236 16905509 6392382 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.32 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.01 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.01 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.40 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.00 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.00 | 11399792 11896295 11222880 11118676 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.63 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.09 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.91 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.91 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.91 | 16289102 18247401 15754350 16644109 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.91 | 16888761 16868541 15749863 15897917 16729912 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.91 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.91 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.91 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.91 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.86 | 21343184 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.63 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.80 | 11597910 12490602 12832656 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.07 | 17922066 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.63 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.26 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.86 | 17710206 15625365 17203757 16767912 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.09 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.64 | 17846226 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.93 | 18724381 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.71 | 16759981 19834688 17453740 15952646 16702368 17050553 16353154 6392382 17938729 17548696 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
13.00 | 17029826 17050553 17976673 19538983 15504454 16251483 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.00 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.00 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.00 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.42 | 16767912 17203757 15625365 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 2093021 20155912 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.18 | 18087811 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.83 | 16045194 16684133 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.14 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.04 | 19225199 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.03 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
11.55 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.55 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.88 | 7505956 6582329 3712494 6587162 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
6.88 | 16010429 17909728 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.71 | 19584973 18020914 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.53 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.04 | 17467628 11989578 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.46 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
11.46 | 11144890 17306315 19322015 19429237 17976673 18640142 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.46 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.46 | 17653716 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.86 | 14652134 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.58 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.07 | 17678736 17638931 17334414 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.61 | 16723640 |